EUA
Sampinute COVID-19 Antigen MIA
FDA Emergency Use Authorization · Celltrion USA, Inc. · Mar 27, 2023
Key facts
| Product | Sampinute COVID-19 Antigen MIA |
|---|---|
| Company | Celltrion USA, Inc. |
| Product type | Magnetic Force-assisted Electrochemical Sandwich Immunoassay (MESIA), Single Target |
| Date | Mar 27, 2023 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: